Clomiphene Citrtae
Brand Names: Clomiphene Citrate
Methodology & AI Transparency ⓘ
Clomiphene Citrtae Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: INDICATIONS & USAGE Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy.
- 2 Real-world patient consensus: Zero-PHI community consensus: 84% favorable across 15 logged regimens (Clomiphene Citrate).
- 3 Typical cash cost range: Dispensing cost comparison spans $172.99 mail/discount cash up to $423.83 uninsured retail (federal NADAC $4.0614).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Clomiphene Citrtae: nausea (11.5%), vomiting (5.1%), blurred vision (2%).
Ask our AI Specialists anything about Clomiphene Citrtae
Clomiphene Citrtae Mechanism, CYP450 Pathways & DailyMed Monograph
INDICATIONS & USAGE Clomiphene citrate is indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. Impediments to achieving pregnancy must be excluded or adequately treated before beginning clomiphene citrate therapy. Those patients most likely to achieve success with clomiphene therapy include patients with polycystic ovary syndrome , amenorrhea-galactorrhea syndrome, psychogenic amenorrhea, post-oral-contraceptive amenorrhea, and certain cases of secondary amenorrhea of undetermined etiology. Properly timed coitus in relationship to ovulation is important.
CLINICAL PHARMACOLOGY Action Clomiphene citrate is a drug of considerable pharmacologic potency. With careful selection and proper management of the patient, clomiphene citrate has been demonstrated to be a useful therapy for the anovulatory patient desiring pregnancy. Clomiphene citrate is capable of interacting with estrogen-receptor-containing tissues, including the hypothalamus, pituitary, ovary, endometrium, vagina, and cervix. It may compete with estrogen for estrogen-receptor-binding sites and may delay replenishment of intracellular estrogen receptors.
Systemic exposure to Clomiphene Citrtae reflects Oral fraction absorbed ranges from 55% to 67% (Clomiphene Citrtae 50) absorption kinetics and dual hepatorenal clearance pathway combining glucuronidation and urinary filtration of clomiphene citrtae, sustaining receptor engagement across a Mean elimination half-life of 10 to 23 hours across adult Clomiphene Citrtae dosing half-life window (oral tmax achieved within 2 to 4 hours following clomiphene citrtae ingestion response profile).
Dosing protocols (50 mg/1 Tablet or Maintenance adjustment for Clomiphene Citrtae based on hepatic/renal clearance) balance efficacy (84.00% patient satisfaction across 15 logs) against nausea (11.5% of reports), headache (7.5% of reports), dizziness (6.4% of reports), with strict avoidance in contraindications hypersensitivity clomiphene citrate is contraindicated in patients with a known hypersensitivity or allergy to clomiphene citrate or to any of its ingredients.; pregnancy clomiphene citrate use in pregnant women is contraindicated, as clomiphene citrate does not offer benefit in this population..
Reconcile eGFR-adjusted medications before escalating Clomiphene Citrtae in polypharmacy regimens.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Clomiphene Citrtae dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CONTRAINDICATIONS Hypersensitivity Clomiphene citrate is contraindicated in patients with a known hypersensitivity or allergy to clomiphene citrate or to any of its ingredients.
- Pregnancy Clomiphene citrate use in pregnant women is contraindicated, as clomiphene citrate does not offer benefit in this population.
Logged Side-Effect Incidence (15 Reports)
Clomiphene Citrtae Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Clomiphene Citrtae)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Managing Hypogonadism: Can Clomiphene citrate Make a Real Difference? (What a 1,279-Person Study Found) Clomiphene citrate is an effective therapy for improving both biochemical as well as clinical symptoms of males suffering from hypogonadism. Andrology • 2022-03-15 • Meta-Analysis | N = 1,279 | 94/100 | PMID 34933414 ↗ |
| What the Latest Evidence Really Says About Clomiphene or enclomiphene citrate for the treatment of male SERM therapy is associated with significantly improved levels of TT, LH, and FSH in hypogonadal men compared to placebo, and significantly enhanced levels of LH and FSH compared to T gel. Archives of endocrinology and metabolism • 2025-10-09 • Meta-Analysis | Multi-cohort | 92/100 | PMID 41066380 ↗ |
| New Insights on Hyperhomocysteinaemia and metabolic syndrome on reproduction in women with: What a 1,000-Participant Study Found In women with PCOS, HHCY contributes to increased pregnancy loss and reduced ovulation, and metabolic syndrome was related to defects in ovulation, conception, pregnancy, pregnancy loss and live birth, indicating that the two... Reproductive biomedicine online • 2019-06-15 • Randomized Controlled Trial | N = 1,000 | 90/100 | PMID 30979610 ↗ |
| Can This Approach Help? Inside the Latest Research on Prospective, randomized comparison between raloxifene and clomiphene citrate for No serious side effects were observed in either group. Fertility and sterility • 2011-09-15 • Randomized Controlled Trial | N = 82 | 88/100 | PMID 21782166 ↗ |
| Can This Approach Help? Inside the Latest Research on Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese Enclomiphene citrate consistently increased serum TT, LH and FSH, restoring normal levels of serum TT. BJU international • 2016-04-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 26496621 ↗ |
Clomiphene Citrtae Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $4.0614/unit (~$121.84/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $423.83 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 15 Anonymous DotMD Community Micro-Logs | $172.99 / mo | View logs ↓ |
| Ro Body & Metabolic Clinic (Licensed Telehealth Cash Program) | State-licensed clinician review • ~2d mail fulfillment | $45.00 consult | Program details |
| Hone Health Hormone & At-Home Biomarker Lab (Licensed Telehealth Cash Program) | State-licensed clinician review • ~3d mail fulfillment | $65.00 consult | Program details |
Clomiphene Citrtae Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Clomiphene Citrtae RxNorm Concept ID | 1093060 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $4.0614 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $423.83 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $172.99 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 84.00% Worth It (15 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Clomiphene Citrtae Patient Community, Cohort Filters & Dosage Logs
Cross-verified Clomiphene Citrtae (estrogen agonist/antagonist) monograph synthesizing RxNorm 1093060, openFDA FAERS signals, and $172.99–$423.83 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Clomiphene Citrtae community threads and patient logs by age, biological sex, dosage, and treatment duration.